Literature DB >> 8191958

Regulation of human immunodeficiency virus infection: implications for pathogenesis.

B A Antoni1, S B Stein, A B Rabson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8191958     DOI: 10.1016/s0065-3527(08)60047-0

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


× No keyword cloud information.
  17 in total

1.  Use of ATP analogs to inhibit HIV-1 transcription.

Authors:  Aarthi Narayanan; Gavin Sampey; Rachel Van Duyne; Irene Guendel; Kylene Kehn-Hall; Jessica Roman; Robert Currer; Hervé Galons; Nassima Oumata; Benoît Joseph; Laurent Meijer; Massimo Caputi; Sergei Nekhai; Fatah Kashanchi
Journal:  Virology       Date:  2012-07-06       Impact factor: 3.616

2.  Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells.

Authors:  B Piret; J Piette
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

3.  A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity.

Authors:  S Nekhai; R R Shukla; A Kumar
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.

Authors:  J Navarro; C Punzón; J L Jiménez; E Fernández-Cruz; A Pizarro; M Fresno; M A Muñoz-Fernández
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Inhibition of recombinant human immunodeficiency virus type 1 replication by a site-specific recombinase.

Authors:  C C Flowers; C Woffendin; J Petryniak; S Yang; G J Nabel
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.

Authors:  H C Lin; M Bodkin; R B Lal; A B Rabson
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Two species of Rev proteins, with distinct N termini, are expressed by caprine arthritis encephalitis virus.

Authors:  A Gazit; P Mashiah; H Kalinski; A Gast; R Rosin-Abersfeld; S R Tronick; A Yaniv
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Inhibition of human immunodeficiency virus type-1 by cdk inhibitors.

Authors:  Irene Guendel; Emmanuel T Agbottah; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  AIDS Res Ther       Date:  2010-03-24       Impact factor: 2.250

9.  Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41.

Authors:  J Arroyo; M Boceta; M E González; M Michel; L Carrasco
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Regulation of macrophage activation and human immunodeficiency virus production by invasive Salmonella strains.

Authors:  S B Mizel; L S Kucera; S H Richardson; F Ciacci; N P Iyer
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.